Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 200
Report Code : HC-1001
Surgical Sealants and Adhesives Market Introduction: Surgical sealants and adhesives market is poised to value over USD 3.34 billion by 2028 end at a CAGR of over 8.2% during the forecast period 2021 to 2028. Surgical sealants are used in surgical incision to prevent fluid leakage during invasive procedures. They are most commonly used in vascular reconstruction to attain mechanical hemostasis. Along with this, surgical sealants are also used for aortic root replacements, suture line replacements, anastomoses and prevention of arterial & venous bleeding. Most of the commercial surgical sealants are flexible, biocompatible and biodegradable. Surgical sealants can be synthetic or natural or a mix of both. Natural surgical sealants mostly include polypeptide/proteins & polysaccharides. Synthetic sealants include polyurethane, polyethene glycol & polymer adhesives respectively. Surgical sealant market is primarily driven by increasing prevalence of invasive surgeries. Traditionally, sutures/wires/staples are used for wound sealing and they pose significant threats like tissue damage, infection and delayed the repair of the tissue. Due to the rapid advancements of technologies, traditional methods are replaced by surgical sealants and let to the burgeoning growth of the market. Along with this, recent advancements have led to the development of biocompatible sealants which decreased the complications associated with invasive surgeries. It also allows normal movement of tissues without any interference on the functioning of the organs. Among the different types of surgical sealants, synthetic adhesives offer high mechanical and adhesive strength. These features made the synthetic surgical sealants most attractive segment over natural sealants and expected to witness significant growth during the forecast period. All these factors have led to the potential growth of surgical sealant market. Surgical sealant market has witnessed robust growth in North America due to increasing adoption among the end-user segments. It is followed by Europe & Asia Pacific regions and expected to be fast growing regions during the forecast period. Latin America and Rest of world surgical sealant markets are expected to account small share in global surgical sealant market due to limited penetration among the end users. Major players included in the Surgical Sealants and Adhesives Market: • Johnson & Johnson (Ethicon, Inc.) • Baxter International, Inc. • Becton, Dickinson and Company • CryoLife, Inc. • Cardinal Health, Inc. • B. Braun Melsungen A.G. • Integra Lifesciences Holdings Corporation • Medline Industries, Inc. • Adhezion Biomedical, LLC. • Tricol Biomedical, Inc. • Vivostat A/S • Advanced Medical Solutions Group plc. • Stryker Corporation • CSL Limited • Ocular Therapeutix, Inc. • MicroVal • GEM Srl. • Hemostasis, LLC. • Péters Surgical • Tissuemed Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends) Surgical Sealant and Adhesives Market Segmentation: By Product • Natural/biological Sealants And Adhesives o Natural/biological Sealants And Adhesives, By Type • Polypeptide/protein-based Sealants And Adhesives o Fibrin-based Sealants And Adhesives o Gelatin-based Sealants And Adhesives o Collagen-based Sealants And Adhesives o Albumin-based Sealants And Adhesives • Polysaccharide-based Sealants And Adhesives o Chitosan-based Sealants And Adhesives o Other Polysaccharide-based Sealants And Adhesives o Natural/biological Sealants And Adhesives, By Origin • Animal-based Sealants And Adhesives • Human Blood-based Sealants And Adhesives • Synthetic & Semisynthetic Sealants And Adhesives o Peg Hydrogels o Cyanoacrylates o Urethane-based Sealants And Adhesives o Other Synthetic & Semisynthetic Sealants And Adhesives By Indication • Tissue Sealing • Surgical Hemostasis • Tissue Engineering By Application • Cardiovascular Surgery • General Surgery • CNS Surgery • Orthopedic Surgery • Cosmetic Surgery • Urological Surgery • Pulmonary Surgery • Ophthalmic Surgery • Other Applications By End User • Hospitals • Clinics • Other End Users By Region • Europe • North America • Asia-Pacific • Middle East and Africa • Latin America Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Surgical Sealants and Adhesives Market By Product, By Indication, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Surgical sealants and adhesives market is poised to value over USD 3.34 billion by 2028 end at a CAGR of over 8.2% during the forecast period 2021 to 2028.
Surgical sealants are used in surgical incision to prevent fluid leakage during invasive procedures. They are most commonly used in vascular reconstruction to attain mechanical hemostasis. Along with this, surgical sealants are also used for aortic root replacements, suture line replacements, anastomoses and prevention of arterial & venous bleeding. Most of the commercial surgical sealants are flexible, biocompatible and biodegradable. Surgical sealants can be synthetic or natural or a mix of both. Natural surgical sealants mostly include polypeptide/proteins & polysaccharides. Synthetic sealants include polyurethane, polyethene glycol & polymer adhesives respectively.
Surgical sealant market is primarily driven by increasing prevalence of invasive surgeries. Traditionally, sutures/wires/staples are used for wound sealing and they pose significant threats like tissue damage, infection and delayed the repair of the tissue. Due to the rapid advancements of technologies, traditional methods are replaced by surgical sealants and let to the burgeoning growth of the market. Along with this, recent advancements have led to the development of biocompatible sealants which decreased the complications associated with invasive surgeries. It also allows normal movement of tissues without any interference on the functioning of the organs. Among the different types of surgical sealants, synthetic adhesives offer high mechanical and adhesive strength. These features made the synthetic surgical sealants most attractive segment over natural sealants and expected to witness significant growth during the forecast period. All these factors have led to the potential growth of surgical sealant market.
Surgical sealant market has witnessed robust growth in North America due to increasing adoption among the end-user segments. It is followed by Europe & Asia Pacific regions and expected to be fast growing regions during the forecast period. Latin America and Rest of world surgical sealant markets are expected to account small share in global surgical sealant market due to limited penetration among the end users.
Major players included in the Surgical Sealants and Adhesives Market: • Johnson & Johnson (Ethicon, Inc.) • Baxter International, Inc. • Becton, Dickinson and Company • CryoLife, Inc. • Cardinal Health, Inc. • B. Braun Melsungen A.G. • Integra Lifesciences Holdings Corporation • Medline Industries, Inc. • Adhezion Biomedical, LLC. • Tricol Biomedical, Inc. • Vivostat A/S • Advanced Medical Solutions Group plc. • Stryker Corporation • CSL Limited • Ocular Therapeutix, Inc. • MicroVal • GEM Srl. • Hemostasis, LLC. • Péters Surgical • Tissuemed Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends)
Surgical Sealant and Adhesives Market Segmentation:
By Product • Natural/biological Sealants And Adhesives o Natural/biological Sealants And Adhesives, By Type • Polypeptide/protein-based Sealants And Adhesives o Fibrin-based Sealants And Adhesives o Gelatin-based Sealants And Adhesives o Collagen-based Sealants And Adhesives o Albumin-based Sealants And Adhesives • Polysaccharide-based Sealants And Adhesives o Chitosan-based Sealants And Adhesives o Other Polysaccharide-based Sealants And Adhesives o Natural/biological Sealants And Adhesives, By Origin • Animal-based Sealants And Adhesives • Human Blood-based Sealants And Adhesives • Synthetic & Semisynthetic Sealants And Adhesives o Peg Hydrogels o Cyanoacrylates o Urethane-based Sealants And Adhesives o Other Synthetic & Semisynthetic Sealants And Adhesives
By Indication • Tissue Sealing • Surgical Hemostasis • Tissue Engineering
By Application • Cardiovascular Surgery • General Surgery • CNS Surgery • Orthopedic Surgery • Cosmetic Surgery • Urological Surgery • Pulmonary Surgery • Ophthalmic Surgery • Other Applications
By End User • Hospitals • Clinics • Other End Users
• Europe • North America • Asia-Pacific • Middle East and Africa • Latin America
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Takeaways
• Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Surgical Sealants and Adhesives Market By Product, By Indication, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Surgical Sealants and Adhesives Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Surgical Sealants and Adhesives Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Surgical Sealants and Adhesives Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Surgical Sealants and Adhesives Market, By Product Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Natural/biological Sealants And Adhesives 7.1.1. Natural/biological Sealants And Adhesives, By Type 7.1.1.1. Polypeptide/protein-based Sealants And Adhesives 7.1.1.1.1. Fibrin-based Sealants And Adhesives 7.1.1.1.2. Gelatin-based Sealants And Adhesives 7.1.1.1.3. Collagen-based Sealants And Adhesives 7.1.1.1.4. Albumin-based Sealants And Adhesives 7.1.1.2. Polysaccharide-based Sealants And Adhesives 7.1.1.2.1. Chitosan-based Sealants And Adhesives 7.1.1.2.2. Other Polysaccharide-based Sealants And Adhesives 7.1.2. Natural/biological Sealants And Adhesives, By Origin 7.1.2.1. Animal-based Sealants And Adhesives 7.1.2.2. Human Blood-based Sealants And Adhesives 7.2. Synthetic & Semisynthetic Sealants And Adhesives 7.2.1. Peg Hydrogels 7.2.2. Cyanoacrylates 7.2.3. Urethane-based Sealants And Adhesives 7.2.4. Other Synthetic & Semisynthetic Sealants And Adhesives 8. Global Surgical Sealants and Adhesives Market, By Indication Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Tissue Sealing 8.2. Surgical Hemostasis 8.3. Tissue Engineering 9. Global Surgical Sealants and Adhesives Market, By Application Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Cardiovascular Surgery 9.2. General Surgery 9.3. CNS Surgery 9.4. Orthopedic Surgery 9.5. Cosmetic Surgery 9.6. Urological Surgery 9.7. Pulmonary Surgery 9.8. Ophthalmic Surgery 9.9. Other Applications 10. Global Surgical Sealants and Adhesives Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Other End Users 11. North America Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2021-2028 12. Latin America Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2021-2028 13. Europe Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2021-2028 14. Asia Pacific Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2021-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Johnson & Johnson (Ethicon, Inc.) 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Baxter International, Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Becton, Dickinson and Company 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. CryoLife, Inc. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Cardinal Health, Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. B. Braun Melsungen A.G. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Integra Lifesciences Holdings Corporation 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Medline Industries, Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Adhezion Biomedical, LLC. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Tricol Biomedical, Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Vivostat A/S 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Advanced Medical Solutions Group plc. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Stryker Corporation 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.CSL Limited 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Ocular Therapeutix, Inc. 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.MicroVal 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.GEM Srl. 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Hemostasis, LLC. 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Péters Surgical 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.Tissuemed Ltd. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Surgical Sealants and Adhesives Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Surgical Sealants and Adhesives Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Surgical Sealants and Adhesives Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Surgical Sealants and Adhesives Market, By Product Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Natural/biological Sealants And Adhesives 7.1.1. Natural/biological Sealants And Adhesives, By Type 7.1.1.1. Polypeptide/protein-based Sealants And Adhesives 7.1.1.1.1. Fibrin-based Sealants And Adhesives 7.1.1.1.2. Gelatin-based Sealants And Adhesives 7.1.1.1.3. Collagen-based Sealants And Adhesives 7.1.1.1.4. Albumin-based Sealants And Adhesives 7.1.1.2. Polysaccharide-based Sealants And Adhesives 7.1.1.2.1. Chitosan-based Sealants And Adhesives 7.1.1.2.2. Other Polysaccharide-based Sealants And Adhesives 7.1.2. Natural/biological Sealants And Adhesives, By Origin 7.1.2.1. Animal-based Sealants And Adhesives 7.1.2.2. Human Blood-based Sealants And Adhesives 7.2. Synthetic & Semisynthetic Sealants And Adhesives 7.2.1. Peg Hydrogels 7.2.2. Cyanoacrylates 7.2.3. Urethane-based Sealants And Adhesives 7.2.4. Other Synthetic & Semisynthetic Sealants And Adhesives
8. Global Surgical Sealants and Adhesives Market, By Indication Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Tissue Sealing 8.2. Surgical Hemostasis 8.3. Tissue Engineering
9. Global Surgical Sealants and Adhesives Market, By Application Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Cardiovascular Surgery 9.2. General Surgery 9.3. CNS Surgery 9.4. Orthopedic Surgery 9.5. Cosmetic Surgery 9.6. Urological Surgery 9.7. Pulmonary Surgery 9.8. Ophthalmic Surgery 9.9. Other Applications
10. Global Surgical Sealants and Adhesives Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Other End Users
11. North America Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2021-2028
12. Latin America Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2021-2028
13. Europe Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2021-2028
14. Asia Pacific Surgical Sealants and Adhesives Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2021-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Johnson & Johnson (Ethicon, Inc.) 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Baxter International, Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Becton, Dickinson and Company 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. CryoLife, Inc. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Cardinal Health, Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. B. Braun Melsungen A.G. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Integra Lifesciences Holdings Corporation 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Medline Industries, Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Adhezion Biomedical, LLC. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Tricol Biomedical, Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Vivostat A/S 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Advanced Medical Solutions Group plc. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Stryker Corporation 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.CSL Limited 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Ocular Therapeutix, Inc. 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.MicroVal 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.GEM Srl. 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Hemostasis, LLC. 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Péters Surgical 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.Tissuemed Ltd. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics